Fig. 3.
Adverse effects monitored by VAS after inh administration of a 1,600-μg THC-CBD inhalation solution. Main trial (n = 8). Values are means. VAS, visual analog scale; inh, pulmonary; THC, delta-9-tetrahydrocannabinol; CBD, cannabidiol.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.